<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
71839-120-01
</NDCCode>
<PackageDescription>
1 VIAL in 1 CARTON (71839-120-01) > 2 mL in 1 VIAL
</PackageDescription>
<NDC11Code>
71839-0120-01
</NDC11Code>
<ProductNDC>
71839-120
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Sodium Nitroprusside
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Sodium Nitroprusside
</NonProprietaryName>
<DosageFormName>
INJECTION
</DosageFormName>
<RouteName>
INTRAVENOUS
</RouteName>
<StartMarketingDate>
20210712
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
ANDA
</MarketingCategoryName>
<ApplicationNumber>
ANDA214971
</ApplicationNumber>
<LabelerName>
BE Pharmaceuticals Inc.
</LabelerName>
<SubstanceName>
SODIUM NITROPRUSSIDE
</SubstanceName>
<StrengthNumber>
50
</StrengthNumber>
<StrengthUnit>
mg/2mL
</StrengthUnit>
<Pharm_Classes>
Vasodilation [PE], Vasodilator [EPC]
</Pharm_Classes>
<DEASchedule/>
<Status>
Active
</Status>
<LastUpdate>
2021-07-24
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20261231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20210712
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>